Filing Flows

Filing Flows › ConocoPhillips (COP) › Q3 2026 › vs Q3 2025

ConocoPhillips (COP) Q3 2026 vs Q3 2025 (year over year)

ConocoPhillips's revenue rose $4.4B (+29%) from $15.0B in Q3 2025 to $19.4B in Q3 2026. The biggest changes: Lower 48 +$2.7B (+26%); EMENA +$986M (+62%); Alaska Segment +$339M (+23%). Operating margin 30.8% against 19.5% (+11.3 pts).

ConocoPhillips, Q3 2026: revenue $19.4B (+29% year over year), operating margin 30.8%, net earnings $4.0B, operating cash flow $7.2B. The chart draws each line against Q3 2025, the increases inside each band.

ConocoPhillips: what changed, Q3 2026 vs Q3 2025ConocoPhillips: what changed, Q3 2026 vs Q3 2025Operating profit$3.1BPre-tax earnings$3.1BLower 48$2.7BNet earnings$2.3BCost of revenue$1.6BCosts & expenses$1.4BOperating cash flow$1.3BFree cash flow (OCF − capex)$1.1BWorking capital & other−$1.0BEMENA$986M

Margins

Q3 2026Q3 2025Change
Operating margin30.8%19.5%+11.3 pts
Net margin20.6%11.5%+9.1 pts
Free cash flow margin20.9%20.0%+0.9 pts

Every line

LineQ3 2026Q3 2025Change%
Lower 48$13.2B$10.5B$2.7B+26%
EMENA$2.6B$1.6B$986M+62%
Alaska Segment$1.8B$1.4B$339M+23%
Canada Operating Segment$1.2B$941M$280M+30%
Asia Pacific Operating Segment$630M$515M$115M+22%
Revenue$19.4B$15.0B$4.4B+29%
Operating profit$6.0B$2.9B$3.1B+104%
Costs & expenses$13.5B$12.1B$1.4B+11%
Pre-tax earnings$6.0B$2.9B$3.1B+104%
Cost of revenue$7.4B$5.9B$1.6B+27%
SG&A$219M$271M−$52.0M-19%
Other operating costs$5.8B$6.0B−$164M-3%
Net earnings$4.0B$1.7B$2.3B+132%
Income tax$2.0B$1.2B$779M+65%
Depreciation & amortization$3.0B$2.9B$88.0M+3%
Working capital & other$189M$1.2B−$1.0B-85%
Operating cash flow$7.2B$5.9B$1.3B+22%
Free cash flow (OCF − capex)$4.1B$3.0B$1.1B+35%
Capital expenditures$3.1B$2.9B$267M+9%

Questions

How much did ConocoPhillips's revenue grow year over year in Q3 2026?

ConocoPhillips's revenue rose $4.4B (+29%) from $15.0B in Q3 2025 to $19.4B in Q3 2026.

What drove ConocoPhillips's revenue change in Q3 2026?

Lower 48 +$2.7B (+26%); EMENA +$986M (+62%); Alaska Segment +$339M (+23%).

Q3 2026 results → · Compare in the interactive Sankey →